Thermo Fisher Announces the Acquisition of Life Technologies




Thermo Fisher announced today that it is acquiring the Life Technologies for $13.6 billion. Life Technologies had been looking to be acquired since the beginning of the year. And the acquisition news initially came out yesterday from a WSJ report. Confirming the report, Thermo Fisher announced the acquisition news early this morning. In a press […]

Thermo Fisher Close to Acquire Life Technologies for $13 Billion: WSJ Reports




It looks like the California based Life Technologies is about to be acquired by the Massachussets based Thermo Fisher. According to the report on Wall Street Journal tonight, Life Technologies and Thermo Fisher are in advanced stages of the acquisition talk and it is expected that the companies can announce the acquisition as early as […]

Ion Torrent to Launch Ion P2 in Mid 2013: Jonathan Rothberg at AGBT 2013




Jonathan Rothberg, CEO of Ion Torrent, announced in a talk at AGBT 2013 that Ion Torrent’ PII chip will be available in mid 2013.  Initially, Ion Proton II was slated to be available in early 2013. During the launch Ion Proton PII chip will produce 32 Gb output at 100bp read length. By the time […]

IonTorrent Sales Beat MiSeq Again: Macquarie Report




IonTorrent beats Illumina’s MiSeq again in the benchtop sequencing machine market, according to the latest report by Macquarie report. BioIT world reporting on the Macquarie’s analysis says that overall the benchtop sequencers market is led by IonTorrent with 62% of the benchtop sequencing market share and MiSeq with the remaining 38% of the market share. IonTorrent’s PGM has […]

NextGenSeek Stories This Week (11/1/13)




It is a pretty exciting week for all things next-generation sequencing. Illumina opened the floodgate with two acquisitions and new developments for MiSeq and HiSeq 2500. Life Technologies partnered with Boston CHildren’s hospital to start a new clinical genomics company, Claritas Genomics. PacBio laid out its plans for the year 2013. Even the ever reticent, […]